Neutrophil function in chronic bronchitis

Page created by Peggy Quinn
 
CONTINUE READING
Eur Resplr J
 1991' 4, 536-543

                         Neutrophil function in chronic bronchitis

                    P. Venge*, S. Rak**, L. Steinholtz**, L. HAkansson*, G. Lindblad***

Neutrophil function in chronic bronchitis. P. Venge, S. Rak, L. Steinholtz, L.     • Dept of Clinical Chemistry, University Hospital,
Hdkansson, G. Lindb/ad.                                                            Uppsala, Sweden.
ABSTRACT: This study was initiated with the question: Do defects In
neutrophil functions predispose patients with chronic bronchitis to their         • • Dept of Lung Medicine, Central Hospital, Viister!s,
                                                                                  Sweden.
recurrent bacterial infections?
   Forty flve patients with chronic bronchitis and recurrent bacterial infec-      •• • Pbarmacia AB, Uppsala, Sweden.
tions were studied. A number of aspects of neutrophil functions reflecting
migratory and phagocytic functions and oxidative metabolism were meas-             Correspondence: P. Venge, Laboratory for Inflamma-
ured in vitro, once in all 45 patients and 3 times in 22 patients over a           tion Research, Dept of Clinical Chemistry, University
period of 6 months.                                                                Hospital, S-751 85 Uppsala, Sweden.
   A great number of abnormalities was found on the first occasion with a
complete normalization for all variables except one at the end of the             Keywords: Chemiluminescence; chemotaxis; chronic
observation period. The number of infectious exacerbatlons was                    bronchitis; infections; neutrophil; phagocyte funclion;
                                                                                  phagocytosis; polymorphonuclear neutrophil; smoking.
significantly higher (p
NEUTROPHIL FUNCTION IN CHRONIC BRONCHITIS                                         537

 this respect was missing for one patient. The smokers        In brief, migration was assayed with purified cells
 had smoked on average for 35:13 yrs (±sn) and on             (1.5x106·ml· 1) suspended in Gey's solution or 10% fresh
 average 14±7 cigarettes per day (:sn). Two patients were     patient serum or pooled normal serum above the
 treated regularly with inhalation steroids but none of the   micropore filter (3 f..tm pore size) (MilJipore Corp.,
 patients was treated with oral steroids. Lung function as    Bedford, MA, USA). Incubation was allowed for 60 min
 evaluated by forced expiratory volume in one second          at 3rC. After fixation and staining of the filters the
 (FEV1)was 79:22% of predicted (±sn) in the patients of       leading-front was read on 3-5 microscopic fields and the
 stage 2 and 50±30% of predicted (±sD) in the patients of     results expressed as means of these readings on
 stage 3. The patients were recruited to the study by         duplicate filters. When random migration or
 advertisement in the local press and a minority had been     chemokinetic responses to pooled normal or patient's own
 seeing a doctor regularly for their disease. The study was   serum were assessed, Gey's solution was put under the
 approved by the local Ethics Committee.                      filter. When chemotaxis was measured either 10%
    Blood samples were drawn once from all 45 patients        zymosan-activated serum or 100 nmoH1 FMLP was put
 at the beginning of the study i.e. period I at October-      under the filter and the cells were suspended in Gey' s
 November. Twenty two of the patients were followed           solution. The intra-assay coefficient of variations for the
 during 32 weeks beginning in October-November and            migration methods ranged from 8-12%.
 ending April-May the following year, and from these
patients two additional blood samplings were made: one
 at period II, i.e. January-February and one at period Ill,   Measurement of neutrophil phagocytosis
i.e. at the end of study in April-May. These 22 patients
were chosen randomly and did not differ from the other           Neutrophil phagocytosis was measured by a kinetic
half with respect to age, sex, smoking habits or numbers      particle uptake method as described in detail previously
of anamnestic infectious exacerbations. Of these 22           [8]. The latex-particles were coated with either human
patients 10 were of stage 2 and 12 of stage 3. Blood          immunoglobulin G (IgG) (Kabi, Sweden) or human IgG
samples were not drawn from any patient with obvious          and fresh serum. The latter particle was designated
clinical signs of ongoing infection. The instructions were    "C3b"-particles since we have demonstrated earlier that
also not to draw blood from a patient within 14 days          the major additional opsonin on these particles is C3b
after a clinical infection. Infection episodes and the        [9]. In brief, 0.5 ml of 4x10 6cells·mJ-1 were mixed with
number of infection days were monitored both by the           0.5 m! of 40xl06 particles·ml· 1• The mixture was kept at
patients through questionnaires and monthly by two            37°C under constant stirring. Aliquots of 100 f..ll were
researchers. Infection episodes were defined as infections    removed every minute for the assessment by means of a
which indicated the use of antibiotics. The patients were     thrombocounter (Coulter Electronics, USA) of free
medically treated according to their individual needs.        latex-particles in !he suspension.
   Thirty apparently healthy laboratory employees served        The rate of disappearance of the latex-particles was
as controls, age range 20-62 yrs (mean age 32 yrs).           used as a measure of the phagocytic rate and expressed
Twenty one were women and 9 men. Six of the controls,         as min. The intra-assay coefficient of variation (CV) of
were smokers. At least one control was assayed on the         the phagocytosis method was 8-10%.
same day as a patient. Of the controls, 8 were assayed
repeatedly i.e. 2-4 times, during the study. There was        Measurement of neutrophil oxidative metabolism
no seasonal variation with respect to neutrophil functions
in the control group.                                             The oxidative metabolism of neutrophils was measured
                                                              by means of chemiluminescence. The production of
                                                              chemiluminescence was assayed in a Biocounter® M2010
                        Methods                               (Lumac B.V., The Netherlands). The detailed method
                                                              has been described previously [10]. In brief, 100 f..ll of
   Venous blood for neutrophil function testing was drawn     cells (1x106 ·ml·1) were mixed with 100 f..ll of luminol 25
in heparinized evacuated blood tubes (Venoject, Terumo,       f..lg·ml· 1 (Merck, Darmstadt, West Germany) or 100 f..ll of
Japan). Venous blood for the preparation of serum was         Jucigenin 100 f,.lg·ml·1 (Sigma Chemical Company, USA).
drawn in evacuated blood tubes without any additives          After this 100 f..ll of stimulus was added and the reaction
(Becton-Dickinsson, New Jersey, USA). White blood cell        recorded continuously on a recorder. As stimuli serum-
counts and differentials were made by means of the            opsonized zymosan 4 mg·mt·1, phorbol myrisate acetate
Technicon Hl analyser (Technicon Instruments Corpora-         nmol (PMA) 10 ng·ml·1 or FMLP 100 nmol·mJ'l were
tion, Tarrytown, NY, USA).                                    used. The activity was expressed in relative light units
   Neutrophil granulocytes were isolated as described [6].    (RLU) from the peak of the curve. The intra-assay
                                                              variations of the methods ranged from 7-12% (CV).

Measurement of neutrophil migration
                                                              Measurement of whole blood chemiluminescence
  Neutrophil migration was assayed by a modified
leading-front technique as described by WlLKINSON [7].          Whole blood chemiluminescence was measured as
The detailed method has been described previously [6].        described in detail previously [11]. In brief, 50 !!I
538                                                              P. VENGE ET AL.

 heparinized blood was mixed with 400 !!1 of Gey's                              indicated. For calculations of the statistics the personal
 solution. To the cells 100 !!l of luminal (1 !!g·ml-1) or 100                  computer program Statgraphics, STSC, USA was
 !!l lucigenin (0.5 !!g·ml-1) was added and allowed to                          used.
 preincubate for 5 min at 37°C in the cuvette in the meas-
 uring chamber of the Biocounter. After this preincubation
 period, 100 !!l of serum-opsonized zymosan particles were                                                        Results
 added and the reaction recorded. The peak activity was
 used for the calculation and the results were expressed as                     Neutrophil migration
 RLU·l0· 6 neutrophils in the blood. The activity was
 corrected for the quenching caused by haemoglobin in                             Table 1 shows the results for the whole group of
 the blood. The intra-assay variation of the methods ranged                     patients. As compared to the control population two
 from 7%-9% (CV).                                                               variables were different: random migration was on average
                                                                                16% higher in the patient group (p
NEUTROPHIL FUNCTION IN CHRONIC BRONCHITIS                                                          539

    The follow-up of half of the patients showed                              MIn
 significant variations over time of random migration
 (p
540                                                               P. VENGB BT AL.

    RLU                                                                           The follow-up study showed a significant (p
NEUTROPHIL FUNCTION IN CHRONIC BRONCHITIS                                               541

 Table 5. - Number of infectious episodes for each 2                 As shown in table 6, migration of patient neutrophils
 month period during the 6 month observation period                  in the presence of patient's own serum was significantly
                                                                     lower (p
542                                                     P. VENGE ET AL.

     We also show that active smoking adversely affects            to postulate that the mobilization of myeloperoxidase from
  several aspects of neutrophil functions, such as chemo-          the neutrophils is enhanced and compensates the defect
  kinesis and luminol-enhanced chemiluminescence, and              found with lucigenin. This is because lucigenin gener-
  may in fact prevent the normal response to the bacterial         ates a signal independent of myeloperoxidase. Luminol,
  challenge. The enhanced migratory activity of the                on the other hand, is strictly dependent on the presence
  neutrophils at period I was most obvious when the                of peroxidases in the reaction [19]. Consequently, the
  capacity to migrate randomly and towards a chemotactic           reduction in luminol-enhanced chemiluminescence, which
  signal such as activated serum (presumably C5fr) was             was observed in smokers, must be explained by an
  measured. These results are in keeping with a previous           adverse effect of smoking on the mobilization or activity
  report on patients with chronic bronchitis and emphysema         of myeloperoxidase. The observation of a reduced activ-
  [3]. In contrast, the response to chemokinetic signals           ity in this respect in smokers is opposite to the findings
  was unaffected at that period but increased at period 11         of others, who reported an increment as a consequence
  when the other variables started to be normalized. We            of smoking [20]. These increments were only seen in
  have shown earlier that chemokinetic signals are produced       patients with high white blood cell counts which may
  in large amounts during active inflammation [10, 15, 16]         explain the seeming discrepancies.
  and it is therefore likely that such signals were produced          Whole blood chemiluminescence is a complicated
  in the studied patients during their active periods of          variable and the results are consequences of the activity
  disease. Possibly, therefore, the neutrophils at period I        of several cells and their relative proportions in the blood.
 were desensitized to further such signals in vitro whereas       There is some evidence that the lucigenin-enhanced
  at period 11, when the disease activity was somewhat             activity primarily reflects monocyte activity [11] and the
 reduced and the production of chemokinetic signals               enhanced activity at period I would therefore indicate an
 consequently lower, the cells had regained their                 increased activity of these cells with a subsequent nor-
 responsiveness. The subsequent complete normalization            malization at periods 11 and Ill.
  at period Ill of all functions reflecting the capacity of the       We conclude from this study that at active ongoing
 neutrophils to move and respond to various signals               disease a number of neutrophil functions are altered in a
 suggests that individuals suffering from chronic bronchitis      manner anticipated from the study of neutrophil functions
 and recurrent infection do not have a constitutional             during episodes of acute bacterial infection. Most such
 predisposition to recurrent infections as a consequence          abnormalities are normalized in parallel to the reduction
 of defects in the migratory capacity of their neutrophils.       of the disease activity which could indicate that
    The phagocytic activity of the neutrophils was seem-          constitutional defects in neutrophil functions are rare
 ingly unaffected and normal at all three periods,                causes of the recurrent bacterial infections in these
 probably excluding any constitutional defects in this            patients. However, the reduced capacity of the
 function, although single patients indeed had subnormal          neutrophils to generate 0 2-metabolites may be an
 activities in this respect. These results agree well with        exception to this general conclusion and in addition to
 those of other authors [4]. In other infection-prone             the adverse effects of smoking on some other functions
 individuals, defects in the capacity to phagocytose IgG-         these defects, constitutional or acquired, may add to the
 coated particles are fairly common findings [10, 16]. In         predisposition of these individuals to their recurrent
 contrast to the normal phagocytic activity of the cells,         bacterial infections. It should also be emphasized that
 the capacity of patient serum to opsonize zymosan-               these data are derived from in vitro studies of neutrophil
 particles was clearly abnormal. Thus, at both periods I          functions and may not necessarily reflect what is ongo-
 and 11 this capacity was considerably enhanced. A similar        ing in the lung.
 enhancement is a general finding in acute infections (to
 be published Pauksens and Venge) and probably reflects                        Acknowledgements: The technical assistance of A.
 activation of the complement system during this period.                     Hull and A-K. Pettersson was greatly appreciated.
The subsequent normalization at period Ill is probably
 another indication of a reduction in the disease activity
 of the group as a whole.                                                                  References
    The oxidative metabolism of cells can be measured by
means of chemiluminescence. Defects in oxidative                  1. Sachs FL. - Chronic bronchitis. Clin Chest Med, 1981,
metabolism of neutrophils is a common cause of increased          2, 79-89.
infection susceptibility. Complete deficiencies are typical       2. Taylor JC, Mittman C, eds. - Pulmonary emphysema
findings in patients suffering from chronic granulomatous         and proteolysis: 1986. Academic Press, New York, 1987.
disease, a severe life-threatening condition [17]. How-           3. Burnett D, Chamba A, Hill SL, Stockley RA.
ever, relative deficiencies have also been associated with        Neutrophils from subjects with chronic obstructive lung disease
an increased susceptibility to infections in children [18].       show enhanced chemotaxis and extracellular proteolysis. Lancet,
                                                                  1987, ii, 1043-1046.
In the present patients the purified cells demonstrated a         4. Fietta A, Bersani C, De Rose V, Grassi FA, Mangiarotti
significant reduction in lucigenin-enhanced chemilumi-            P, Uccelli M, Grassi C. - Evaluation of systemic host defense
nescence at periods 11 and Ill which may suggest a                mechanisms in chronic bronchitis. Respiration, 1988, 53,
constitutional defect in handling 0 2 • However, to               37-43.
explain the fact that chemiluminescence enhanced with             5. Medical Research Council. - Committee on the etiology
luminol was seemingly normal at these periods one has             of chronic bronchitis. Lancet, 1965, i, 775-779.
NEUTROPHIL FUNCfiON IN CHRONIC BRONCHITIS                                               543

 6. H~kansson L, Venge P.- The influence of serum on ran-            19. Williams AJ, Cole PJ. - The onset of polymorphonuclear
 dom migration and chemotaxis of polymorphonuclear                   leukocyte membrane-stimulated metabolic activity. Immunology,
 leukocytes. Methodological evaluation using sera from infection-    1981, 43, 733-739.
 prone patients and normals. Scand J Immunol, 1980, 11,              20. Ludwig PW, Hoidal JR. - Alterations in leukocyte
 271-282.                                                            oxidative metabolism in cigarette smokers. Am Rev Respir Dis,
 7. Wilkinson PC.               Chemotaxis and inflammation.         1982, 126, 977-980.
 Churchill Livingstone, Edinburgh and London, 1974.
 8. HM
You can also read